Literature DB >> 7850756

Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.

S Y Park1, Y S Kang, B G Kim, S H Lee, E D Lee, K H Lee, K B Park, J H Lee.   

Abstract

DNA samples from 26 cervical carcinoma and normal tissue pairs were studied by restriction fragment length polymorphism (RFLP) analysis to determine the frequency of loss of heterozygosity (LOH) on 17p. Allelic loss in the p13.1 region of chromosome 17, known to contain the TP53 locus, was not detected in any of 10 informative cases. Instead, LOH was detected on 17p13.3 in eight (40%) of 20 informative cases with at least one of two 17p13.3 markers. Examination of the intragenic region of p53 in the same samples using polymerase chain reaction (PCR)-RFLP analysis showed no LOH in the gene (none of 16 informative individuals).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7850756     DOI: 10.1016/0165-4608(94)00103-i

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  p53 expression in carcinoma of the cervix.

Authors:  C R Hunt; R J Hale; C H Buckley; J Hunt
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix.

Authors:  C S Herrington; M Worsham; S A Southern; P Mackowiak; S R Wolman
Journal:  Mol Pathol       Date:  2001-06

Review 3.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

4.  Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.

Authors:  A M Kersemaekers; J Hermans; G J Fleuren; M J van de Vijver
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

Review 5.  The molecular genetics of cervical carcinoma.

Authors:  P A Lazo
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

6.  OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.

Authors:  Rui Tong; Qing Yang; Chunyan Wang; Fangfang Bi; Bing Jiang
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

7.  Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.

Authors:  T Takahashi; H Konishi; K Kozaki; H Osada; S Saji; T Takahashi; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1998-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.